Alembic Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Alembic Pharma	Natco Pharma	Jubilant Pharmova
Operational Metrics
Pharmaceuticals
US DMF Filings	141.0 .	58.0 .	98.0 .
Number of ANDA's Filed in USA	269.0 .	51.0 .	100.0 .
Number of ANDA's Approved By USFDA	226.0 .	41.0 .	62.0 .
Number of ANDA's Filed in Latam	14.0	n/a	n/a
Number of ANDA's Approved by Latam	4.0	n/a	n/a
Number of ANDA's Filed in South Africa	21.0	n/a	n/a
Number of ANDA's Approved by South Africa	7.0	n/a	n/a
Number of ANDA's Filed in Australia	17.0	n/a	n/a
Number of ANDA's Approved by Australia	14.0	n/a	n/a
Number of ANDA's Filed in Canada	21.0	n/a	24.0
Number of ANDA's Approved by Canada	20.0	n/a	24.0
Number of ANDA's Filed in Europe	21.0	n/a	38.0
Number of ANDA's Approved in Europe	19.0	n/a	37.0
R&D as a % of Total Sales	8.0 %	9.1 %	0.18 %
Financials
5 yr Average ROE	12.89 %	15.58 %	7.82 %
5yr average Equity Multiplier	1.39	1.17	1.96
5yr Average Asset Turnover Ratio	0.86	0.48	0.61
5yr Avg Net Profit Margin	11.15 %	26.79 %	6.45 %
Price to Book	3.17	1.92	2.61
P/E	26.55	10.79	36.0
5yr Avg Cash Conversion Cycle	9.46 Days	4.27 Days	-39.98 Days
Inventory Days	99.1 Days	91.91 Days	74.06 Days
Days Receivable	66.32 Days	93.3 Days	45.59 Days
Days Payable	164.9 Days	134.54 Days	149.89 Days
5yr Average Interest Coverage Ratio	30.59	60.49	3.78
5yr Avg ROCE	15.26 %	19.09 %	8.15 %
5yr Avg Operating Profit Margin	17.29 %	34.0 %	16.76 %
5 yr average Debt to Equity	0.14	0.06	0.55
5yr CAGR Net Profit	-12.64 %	33.73 %	0.08 %
5yr Average Return on Assets	9.32 %	13.46 %	4.12 %
Shareholdings
Promoter Holding	69.74 %	49.48 %	47.68 %
Share Pledged by Promoters	0.0	0.0	5.4 %
Change in Promoter Holding (3 Yrs)	0.13 %	0.68 %	-3.0 %
Change in Mutual Fund Holding (3 Yrs)	3.19 %	-5.43 %	6.74 %

Business

	Alembic Pharma	Natco Pharma	Jubilant Pharmova
Product Wise Break-Up	Product Wise Break-Up Formulations 83.56 Active Pharmaceutical Ingredient (API) 16.44 Crop Health 0 API(Domestic & Exports) 0 Formulation 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0	Product Wise Break-Up India Branded pharmaceuticals 0 Active Pharmaceutical Ingredient (API) 0 0 Formulations 85.6 Radiopharmaceuticals 0 Nutritional products 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 0 Life science chemicals 0 Specialty intermediates 0 Solid dosage formulations 0 Crop Protection 3.6 Active Pharmaceutical Ingredient (API) 3.7 Formulations 0 Others 7.1	Product Wise Break-Up India branded pharmaceuticals 0.7 Active Pharmaceutical Ingredient (API) 0 Contract Manufacturing 17.66 Formulation 0 Radiopharmaceuticals 46.89 Nutritional products 0 Anti-allergic 9.75 Active Pharmaceutical Ingredient (API) 7.91 Contract Research and Development Services 7.87 Life science chemicals 0 Specialty intermediates 0 Solid dosage formulations 8.71 Crop Health 0 API(Domestic & Exports) 0 Formulations 0 Others 0.51
Product Wise Break-Up	Product Wise Break-Up Formulations 83.56 Active Pharmaceutical Ingredient (API) 16.44 Crop Health 0 API(Domestic & Exports) 0 Formulation 0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0	Product Wise Break-Up India Branded pharmaceuticals 0 Active Pharmaceutical Ingredient (API) 0 0 Formulations 85.6 Radiopharmaceuticals 0 Nutritional products 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 0 Life science chemicals 0 Specialty intermediates 0 Solid dosage formulations 0 Crop Protection 3.6 Active Pharmaceutical Ingredient (API) 3.7 Formulations 0 Others 7.1	Product Wise Break-Up India branded pharmaceuticals 0.7 Active Pharmaceutical Ingredient (API) 0 Contract Manufacturing 17.66 Formulation 0 Radiopharmaceuticals 46.89 Nutritional products 0 Anti-allergic 9.75 Active Pharmaceutical Ingredient (API) 7.91 Contract Research and Development Services 7.87 Life science chemicals 0 Specialty intermediates 0 Solid dosage formulations 8.71 Crop Health 0 API(Domestic & Exports) 0 Formulations 0 Others 0.51
Location Wise Break-Up	Location Wise Break-Up Rest of the World 60.76 India 39.24 USA 0 China 0 Americas and Europe 0	Location Wise Break-Up India 12.44 Americas and Europe 0 Rest of the World 16.18 USA 71.37 China 0 Others 0.01	Location Wise Break-Up India 2.76 Americas and Europe 91.35 Rest of the World 5.89 USA 0 China 0
Therapeutic Area Break-Up	Therapeutic Area Break-Up Others 100	-	-

Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE